Skip to content

DR. DECUPERE MARC

Active
Private limited companyfounded 20224 yrs activeMunkendoornstraat(Bel) 294, 8510 Kortrijk, BelgiumKBO/BCE: BE 0787.843.601

The computed 12-month bankruptcy probability of DR. DECUPERE MARC is 2.6% (moderate). The 2024 annual accounts show equity of €1.07M and a net result of €230k. Equity is growing by ~54.6% per year across the filed fiscal years. The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2024
93 / 100
Excellent▼ -7 vs 2023
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency100=
Growth78=
Stability94
Bankruptcy probability, 12 months
2.6% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €100k at 30 days acceptable
Liquidity ample (current ratio 5.3 against 4.26 in 2023), and 18.8% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 4 years 0 10 y
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
81.2%
Return on assets
17.5%
Age of the figures
20 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 26-06-2025, 35 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
not confirmed
2024
35 d early
2023
37 d early
2022
7 d early
← before the deadline after the deadline →
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, abbreviated schema

Equity
€1.07M▲ 27.5%
2023 · €835k
2022: €153k 2023: €835k
2022 → 2024
Total assets
€1.31M▲ 20.3%
2023 · €1.09M
2022: €266k 2023: €1.09M
2022 → 2024
Net result
€230k▼ 66.3%
2023 · €683k
2022: €153k 2023: €683k
2022 → 2024
Working capital
€1.06M▲ 27.4%
2023 · €833k
2022: €151k 2023: €833k
2022 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line202220232024Trend
Equity€153k-€835k▲ 447%€1.07M▲ 27.5%
Operating result€198k-€908k▲ 359%€302k▼ 66.8%
Net result€153k-€683k▲ 347%€230k▼ 66.3%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€250k€500k€750k€1.00MOperating result 2022: €198k€198kNet result 2022: €153k€153kOperating result 2023: €908k€908kNet result 2023: €683k€683kOperating result 2024: €302k€302kNet result 2024: €230k€230k202220232024
The operating result falls in 2024; 2024 is 67% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €1.31M
Fixed assets €4k▲ 77.8%
Current assets €1.31M▲ 20.1%
Equity and liabilities €1.31M
Equity €1.07M▲ 27.5%
Debt €246k▼ 3.5%
The debt ratio falls from 23.4% to 18.8%: equity grows while debt is paid down.
Key figures and ratios
2024 value · change against 2023
EBITDA
€304k
2023 · €909k
Cash flow
€232k
2023 · €684k
Solvency
81.2%
2023 · 76.6%
Current ratio
5.30
2023 · 4.26
Quick ratio
5.30
2023 · 4.26
Debt / equity
0.23
2023 · 0.31
ROE
21.6%
2023 · 81.7%
ROA
17.5%
2023 · 62.6%
Interest coverage
896.00
2023 · 645.68
Debt
€246k
2023 · €255k
Debt ≤ 1 year
€246k
2023 · €255k
Income taxes
€74k
2023 · €224k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet Code20232024
Assets
Total assets20/58€1.09M€1.31M
Fixed assets21/28€2k€4k
Tangible fixed assets22/27€2k€4k
Furniture and vehicles24€2k€4k
Current assets29/58€1.09M€1.31M
Amounts receivable within one year40/41€894k€897k
Other amounts receivable41€894k€897k
Cash at bank and in hand54/58€192k€407k
Deferred charges and accrued income490/1€2k€3k
Equity and liabilities
Total equity and liabilities10/49€1.09M€1.31M
Equity10/15€835k€1.07M
Contributions10/11€1€1=
Reserves13€835k€1.07M
Distributable reserves133€835k€1.07M
Amounts payable17/49€255k€246k
Amounts payable within one year42/48€255k€246k
Trade debts44€2k€159k
Suppliers440/4€2k€159k
Taxes, remuneration and social security45€234k€85k
Taxes450/3€234k€85k
Remuneration and social security454/9€0-
Other amounts payable47/48€19k€2k
Income statement Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€893€3k
Other operating charges640/8€2k€2k
Gross operating margin9900€911k€306k
Operating profit (loss)9901€908k€302k
Financial income75/76B-€2k
Recurring financial income75-€2k
Financial charges65/66B€1k€340
Recurring financial charges65€1k€340
Profit (loss) for the period before taxes9903€907k€304k
Income taxes67/77€224k€74k
Profit (loss) for the period9904€683k€230k
Profit (loss) for the period to be appropriated9905€683k€230k
Appropriation of the result
Profit (loss) to be appropriated9906€683k€230k
Transfer to equity691/2€683k€230k
To other reserves6921€683k€230k

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2025
26-06
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial Equity above €1MEq €1.07M ▲27.5%
3 profitable years in a row build equity to €1.07M.
24-06
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Highest result since 2022net €683k ▲347%
Operating result €908k, net result €683k, both a record.
31-12
Financial Equity above €500kEq €835k ▲447%
2 profitable years in a row build equity to €835k.
24-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kortrijk · 1 establishment unit since 2022
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Munkendoornstraat(Bel) 2948510 Kortrijk
Ground area
13.9 ha
Building footprint
3.5 ha
Volume, LiDAR
1,118 m³
2 parcels, Flanders · tallest building 10.6 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
DR. DECUPERE MARC
President Kennedylaan(Kor) 4, 8500 KortrijkSpecialist medical practice
since 20222.333.289.963
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
34026A0631/00H000 Flanders 13.7 ha 1 · 3.4 ha -
34005C1220/00C000 Flanders 2,550 m² 1 · 279 m² 10.6 m · 1 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded30-06-2022
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers

Data from official sources, last processed on 12-09-2026. Scores and ratios are computed by Checked and are not a credit decision.